UPClytics

AstraZeneca Group

Operating company

HQ: United Kingdom

Total cases
13
Claimant-side
4
Respondent-side
9

Not counted above: 3 file-access requests (R. 262.1(b) RoP), where someone asked to read a case file. View

AstraZeneca Group has been party to 13 Unified Patent Court cases, 4 times as claimant and 9 times as respondent. The most recent on record is UPC CoA 152/2026 at the Court of Appeal.

Group members
1 entities · 13 cases combined
Top opponents
  • Samsung Group8

More opponents

Top opponent firms
  • Simmons & Simmons8

More opposing firms

Top firms retained
  • Freshfields13

More of its firms

Start 14-day free trialEvery opponent and every firm acting for and against AstraZeneca Group.Already a user? Sign in
Recent cases
Latest filings involving this group and its entities.
View all cases
  • 2026-09-15UPC CoA 152/2026File-access requestCarpmaels & Ransford LLP v Samsung Bioepis NL B.V.
  • 2026-09-15UPC CoA 153/2026File-access requestCarpmaels & Ransford LLP v Amgen Zdravila D.O.O.
  • 2025-08-14UPC CoA 750/2025WithdrawnSamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-08-13UPC CoA 744/2025WithdrawnSamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-07-22UPC CFI 674/2025—Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-01-23UPC CFI 51/2025—Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-01-22UPC CFI 40/2025Costs onlySamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-01-21UPC APP 3053/2025—Amgen GmbH v Alexion Pharmaceuticals, Inc.
  • 2024-11-08UPC APP 60271/2024File-access requestName not displayed for GDPR reasons. Represented by Jochen HÖHFELD v Alexion Pharmaceuticals, Inc.
  • 2024-10-31UPC CFI 642/2024WithdrawnAMGEN Switzerland AG Vilniaus filialas v Alexion Pharmaceuticals, Inc.